Partners in the COVID-19 Therapeutics Accelerator have announced grants of $20 million to three institutions--the University of Washington, University of Oxford, and La Jolla Institute for Immunology - to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic.
The grants mark the first investments to come from the COVID-19 Therapeutics Accelerator, a large-scale initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard, to speed the development of and access to therapies for COVID-19.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article